Priser
Platform
Blog
Om os
Download
Faes Farma
Faes Farma
Bolsa de Madrid
0

Om

Faes Farma, S.A. is a publicly traded Spanish pharmaceutical company founded in 1933, specializing in the research, development, production, and marketing of pharmaceutical products, healthcare items, over-the-counter medicines, food supplements, personal care treatments, and raw materials for the pharmaceutical industry. Headquartered in Leioa, Biscay, Spain, it operates through key segments including Pharmaceutical and Healthcare Specialties, Animal Nutrition and Health via its FARM Faes division, and Pharmaceutical Raw Materials. The company addresses diverse therapeutic areas such as cardiovascular, respiratory, central nervous system, allergy, venous insufficiency, metabolic disorders, ophthalmic conditions, osteoporosis, and irritable bowel syndrome. With approximately 1,775 employees, Faes Farma maintains a strong international footprint, exporting to over 100 countries, particularly growing in Latin America and Africa, while conducting most business in Spain and Portugal. Recent expansions include a state-of-the-art 60,000 m² factory in Derio to enhance production capacity and support its role as a global player in the healthcare sector.

Markedsdata leveret af TwelveData og Morningstar

Aktiemarkedet kan gå både op og ned. Selvom investeringer i aktier historisk set har givet investorer et positivt afkast på langt sigt, er der ingen garanti for fremtidige afkast. Der er derfor en risiko for, at du ikke får de investerede penge tilbage.

INVESTER I FAES FARMA MED ENDAVU: Køb Faes Farma ($FAE) aktier gennem Endavu’s investeringsplatform. Hos Endavu kan du købe og sælge aktier i Faes Farma, og handle med aktier, fraktionaler, ETF'er og andre finansielle instrumenter. Endavu tilbyder handel uden kurtage på amerikanske aktier. Endavu tilbyder lav kurtage på tværs af aktier. Handl med over 30.000 forskellige aktier og udenfor markedsåbningstider.

Information

TickerFAE
Land
Spanien
Antal medarbejdere2.677
Hjemmesidefaesfarma.com
SektorSundhed
IndustriLægemiddelproducenter - Specialitet og generisk

Udbytter

0,19EUR
'21
0,03EUR
'22
0,03EUR
'23
0,16EUR
'24
0,18EUR
'25
0,04EUR
'26
Ex-udbytte-dato8. jan. 2026
Udbytteafkast3,65%

Analytikerskøn

Baseret på 4 analytikere

Stærkt købKøbHoldSælgStærkt sælg
0%25%50%25%0%